Fosun Health

What Fosun Health does

Fosun Health (复星健康), formally Shanghai Fosun Health Technology (Group) Co., Ltd., is a private medical technology and healthcare services company headquartered in Shanghai, founded in 2010 as a controlling subsidiary of the publicly listed Shanghai Fosun Pharmaceutical Group (600196.SH, 02196.HK). The company operates an integrated online-offline healthcare platform combining 19 controlled medical institutions with 6,500 licensed beds across five major Chinese economic zones (Greater Bay Area, Yangtze River Delta, Beijing-Tianjin-Hebei, Central China, Sichuan-Chongqing), 9 internet hospital licenses, and a next-generation Cloud HIS information system linking the network. Flagship assets include the Grade 3 tertiary Foshan Fosun Chancheng Hospital (ranked #1 nationally in the social-run medical single-hospital benchmark for eight consecutive years) plus additional specialty hospitals in oncology, orthopedics, geriatric care, pediatrics, and plastic surgery. The portfolio also includes international medical tourism channels (Hong Kong, Macau, Indonesia, Bangladesh, Mongolia, Middle East) and three hospitals designated as Hong Kong-Macau medication and device pilot institutions, enabling access to roughly 60 international innovative drugs and devices ahead of mainland NMPA approval.

Core products include the Cloud HIS smart medical cloud platform, the AI Village Doctor Assistant 2.0 (NLP-based document interpretation, insurance claims, policy consultation), AI-assisted nursing applications (risk prediction, chronic disease management), and an AI-driven medical research platform supporting proposal writing and evidence-based medicine development. The Shanghai Fosun Foundation Village Doctor Project operates as an ESG-supported training network covering 78 counties, 25,000 village doctors, and 16.34 million rural residents.

The business model combines fee-for-service hospital revenue across the 19-institution network, digital health subscription-like recurring revenue from 9 internet hospital licenses, pharmaceutical revenue (innovative drugs including HANSIZHUANG and HLX43), and managed insurance integration revenue from partnerships with 55+ domestic and international insurers providing dual medical-insurance enablement. Customer segments span individual patients and families (primary), insurance companies (B2B channel), and government rural healthcare programs (partnership/ESG). Distribution combines direct enterprise channels (hospital network), self-serve digital channels (internet hospital platform), reseller channels (insurance network), and selective international expansion. The company is privately held within the Fosun International conglomerate, with a CNY 300 million strategic investment from Foshan Chancheng Urban Investment in 2024 carrying an IPO promise for the hospital unit.

Name

Fosun Health

Legal name

上海复星健康科技(集团)有限公司

Website

https://fosunhealth.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Fosun Health operates 19 controlled medical institutions with 6,500 beds across China, complemented by internet hospital platforms, AI clinical tools, and insurance partnerships serving patients, families, insurers, and rural healthcare programs as a Fosun Pharmaceutical subsidiary.

Ownership category

akta.pro rank

Product category

Integrated Hospital and Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110), Ambulatory Health Care Services (621)

SIC

Services-Hospitals (8060), Services-Health Services (8000)

akta.pro primary industry

Healthcare On‑Demand Platforms (Telehealth, Home Care, Nursing) (BPAMAHAH)

akta.pro secondary industry

Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD)

Keywords

• Integrated hospital network
• Internet hospital services
• Specialty medical centers
• Digital health platform
• Healthcare management services

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Medical Services Revenue: Revenue generated from hospital services, outpatient consultations, inpatient care, surgeries, and specialized medical treatments across 19 controlled medical institutions including Grade 3 hospitals, specialized hospitals, and clinics.
2. Pharmaceutical Products Revenue: Revenue from innovative drugs including HANSIZHUANG and HLX43. Innovative drug revenues increased 18% in the first three quarters of 2025, with a focus on clinical needs-driven biopharma research in oncology, neurology, and supportive care.
3. Internet Hospital Services: Digital healthcare services through 9 internet hospital licenses providing online consultations, medication purchases, health management, and chronic disease management for families.
4. Insurance Integration Services: Revenue from partnerships with over 55 domestic and international insurance institutions, providing medical and insurance dual-enablement services across the healthcare network.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Fosun Health operates a network of 19 controlled medical institutions — including comprehensive hospitals, specialty hospitals, and clinics — with 6,500 licensed beds across China's five major economic zones, combined with digital healthcare services through 9 internet hospital licenses. It also distributes innovative pharmaceuticals and provides dual medical-insurance enablement services through partnerships with 55+ insurance institutions. The core deliverable is integrated inpatient and outpatient care across specialties (oncology, orthopedics, geriatrics, pediatrics, plastic surgery, rehabilitation), augmented by AI-powered clinical decision support and online-offline continuity.

Product overview

Fosun Health operates a comprehensive healthcare ecosystem combining a network of 19 physical hospitals and clinics with digital health services. The core platform centers on the Cloud HIS (云HIS) system, a next-generation smart medical cloud platform enabling integrated hospital operations across the network. Digital services are augmented by the AI Village Doctor Assistant 2.0, an AI-powered tool supporting grassroots healthcare workers. The company serves patients and families through online-offline integrated services including medical consultations, health management, and specialized treatments in oncology, orthopedics, and other specialties. Fosun Health's structure integrates physical medical institutions (including flagship Foshan Fosun Chancheng Hospital) with digital capabilities including 9 internet hospital licenses and cloud-based hospital information systems.

Differentiator

Problem solved

Functional benefit

Products and services

• Hospital Network Medical Services Comprehensive outpatient, inpatient, surgical, and specialty care delivered across Fosun Health's 19 controlled medical institutions (including 1 Grade A tertiary hospital, 5 Grade 3 hospitals, 8 Grade 2 hospitals, specialty hospitals, clinics, and third-party testing institutions) spanning the Greater Bay Area, Yangtze River Delta, Beijing-Tianjin-Hebei, Central China, and Sichuan-Chongqing, with 6,500 licensed beds, 76 provincial/municipal key specialties, and 5 GCP-certified hospitals. Designed for patients and families seeking continuous care across life stages.
• Internet Hospital Services Digital healthcare services delivered through 9 internet hospital licenses, providing online consultations, medication purchases, health management, vaccination booking, health education, and chronic disease management for individual patients and families. Enables online-offline integrated care delivery in conjunction with the physical hospital network.
• AI Village Doctor Assistant 2.0 AI-powered digital assistant for rural doctors that provides intelligent interpretation of lab reports, health examination reports, and other medical documents, plus insurance claims processing, policy consultation, and scan-to-login access. Built with a language model optimized for village doctors' actual work environment, and designed to free grassroots doctors from paperwork so they can spend more time with patients.

Quantifiable outcome

• 18% increase in innovative drug revenues in first three quarters of 2025
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Six partnerships are on record, tiered core and major.

• Insurance Partners (55+ institutions)coreStrategic or Co-development Partner · 1 January 2025Strategic partnerships with over 55 domestic and international insurance institutions enabling dual medical-insurance services and integrated healthcare-payment solutions across the hospital network.
• Foshan Fosun Chan Hospital Partner Hospitals (7 hospitals)coreStrategic or Co-development Partner · 1 January 2025Seven cooperating hospitals including Foshan Fosun Chan Hospital, Wuhan Puren Hospital, Nanjing BenQ Hospital, Suzhou BenQ Hospital, Shenzhen Hengsheng Hospital, Zhanjiang Lingnan Orthopedic Hospital, and Guangzhou Fosun Chan Hospital participating in village doctor training programs.
• Guangzhou Baiyun District GovernmentmajorStrategic or Co-development Partner · 1 January 2025Strategic cooperation agreement signed with Guangzhou Baiyun District Government for regional healthcare development and medical service expansion.
• Guangdong Pharmaceutical University (广东药科大学)coreStrategic or Co-development Partner · 1 January 2023Strategic cooperation with Guangzhou New City Hospital forming a close collaboration mechanism; hospital renamed to 'Guangdong Pharmaceutical University Guangzhou Fosun Chancheng Hospital' as university-affiliated clinical institution.
• Fudan University Affiliated Pediatric HospitalcoreStrategic or Co-development Partner · 1 January 2023Co-construction partnership with Fudan University Affiliated Pediatric Hospital for high-end pediatric international hospital (Shanghai Xingchen Children's Hospital, also known as Fudan Pediatric New Hongqiao Branch).
• Shanghai Fosun Foundation - Village Doctor Project (上海复星公益基金会乡村医生项目)coreStrategic or Co-development Partner · 1 January 2017Village doctor project covering 16 provinces and autonomous regions across 78 counties, benefiting 25,000 village doctors and 16.34 million rural residents. Includes expert teaching programs, AI village doctor assistant, and rural healthcare capacity building.

Scale indicators12 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Phoenix Healthcare Group: Hong Kong-listed private hospital network operator in China (51 hospitals and clinics as of recent disclosures) covering general hospitals, specialty centers, and clinics; comparable integrated hospital-network business model with similar Chinese-market focus and tiered institution mix.
• China Resources Medical Holdings: One of China's largest hospital groups operating ~100 member hospitals across general and specialty categories; directly comparable as a multi-region Chinese hospital network operator with both general tertiary and specialty facilities, though state-owned versus Fosun's private structure.
• Aier Eye Hospital Group: China's largest specialty hospital chain with 800+ eye hospitals and clinics; comparable as a multi-region private specialty hospital network with academic affiliations and tiered institutional model similar to Fosun's specialty facilities.
• Topchoice Medical Corporation: Shanghai-listed specialty medical services group operating dental, ophthalmology, and auxiliary reproductive hospitals across China; comparable multi-specialty private hospital network with tiered institutional structure and similar geographic footprint.
• iKang Healthcare Group: Private Chinese healthcare services operator historically focused on physical examination centers and medical clinics across China; comparable outpatient/private healthcare delivery model targeting Chinese consumers with insurance and corporate clients.

Emerging players

• WeDoctor (We Doctor): Chinese digital health platform combining internet hospitals with physical medical institution partnerships; comparable integrated online-offline healthcare delivery model though with digital-first emphasis versus Fosun's hospital-first model.

Broad incumbents

• JD Health International: Hong Kong-listed Chinese digital health and pharmacy platform with extensive online consultation, drug retail, and consumer healthcare services; overlapping telemedicine and online-offline integration ambitions though primarily a digital-first player.
• Ping An Healthcare and Technology: Hong Kong-listed Chinese internet healthcare platform backed by Ping An Group; comparable integrated medical-insurance enablement model and digital healthcare services across Chinese consumer and enterprise segments.
• Alibaba Health Information Technology: Hong Kong-listed Chinese healthcare and pharmaceutical e-commerce platform with internet hospital operations; comparable digital health, pharmaceutical distribution, and consumer-facing healthcare offerings across China.
• IHH Healthcare Berhad: Asia-Pacific hospital operator (Mount Elizabeth, Gleneagles, Parkway brands) operating 80+ hospitals across Malaysia, Singapore, Turkey, and India; comparable multi-region private hospital network operator at meaningful scale though focused outside mainland China.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries13 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fosun Health